Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Hospira, Inc.    HSP

No quotes available
-- USD   0.00%
2015 HOSPIRA : Announces First Installation of Plum 360™ Infusion S..
2015 HOSPIRA : Announces First Installation of Plum 360(TM) Infusion Syst..
2015DJPFIZER : Buy of Hospira Gets Green Light
 SummaryQuotesNewsAnalysisCalendarCompanyFinancialsConsensus 
Company
Hospira, Inc. is a pharmaceutical and medication drug delivery company, which engages in providing injectable drugs and infusion technologies.Its portfolio includes generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management products.The company... 
Sector
Pharmaceuticals
Calendar
11/02Earnings Release
More about the company
Latest news on HOSPIRA, INC.
2015 HOSPIRA : Announces First Installation of Plum 360™ Infusion System With H..
2015 HOSPIRA : Announces First Installation of Plum 360(TM) Infusion System With Hosp..
2015DJPFIZER : Buy of Hospira Gets Green Light
2015DJPFIZER : Gets U.S. Approval to Acquire Hospira, With Divestitures
2015 HOSPIRA : Expert committee BACKS Hospira’s InflectraTM
2015 HOSPIRA : Charleston Area Medical Center Integrates Smart Pump Technology to Adv..
2015 HOSPIRA : TGA Approves First mAb Biosimilar
2015 HOSPIRA : Applauds UK's NICE for Issuing Adoption Resource to Help Drive the Int..
2015DJPFIZER : Gets EU Green Light for Hospira Merger
2015 HOSPIRA : Pfizer wins EU approval for $15 billion Hospira buy
More news
Sector news : Generic Pharmaceuticals
09/23DJAMGEN : FDA Approves Amgen's Biosimilar Version of Humira -- 2nd Update
09/23DJAMGEN : FDA Approves Amgen's Biosimilar Version of Humira -- Update
09/23DJAMGEN : FDA Approves Amgen's Biosimilar Version of Humira
09/23 Endo International CEO steps down, Campanelli named successor
09/23DJSHIRE : Files 8K - Direct Or Off-Balance Sheet Financial Obligation
More sector news : Generic Pharmaceuticals
4-Traders Strategies on HOSPIRA, INC. 
2013End of the technical recovery
More Strategies
News from SeekingAlpha
04/19 New Management At ICU Medical Has Produced Positive Results
03/21 PFIZER : 30%+ Discount With 4% Yield
2015 PREMARKET BIOTECH DIGEST : Trouble For Anticoagulants, Gilead U.S. Hep C Sales
2015 Hospira Acquisition To Add Shareholder Value For Pfizer
2015 Activision Blizzard, United Continental set to join S&P 500
Advertisement
Income Statement Evolution
More Financials
Managers
NameTitle
F. Michael Ball Chief Executive Officer & Director
John C. Staley Non-Executive Chairman
Matthew R. Stober Senior Vice President-Operations
Thomas E. Werner Chief Financial Officer & Senior Vice President
Sumant Ramachandra Chief Scientific Officer & Senior Vice President
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
HOSPIRA, INC.0.00%0
SUN PHARMACEUTICAL IND..-5.02%28 165
OTSUKA HOLDINGS CO LTD5.19%25 163
BIOMARIN PHARMACEUTICA..-7.03%16 634
ONO PHARMACEUTICAL CO...-37.03%15 857
ASPEN PHARMACARE HOLDI..5.62%10 757
More Results